ONLINE DATABASE SEARCH -
OI-LS-369--MEMO
1.
60318 OI-LS-369;
PUBMED-OI-3/5/2007
Emerging host cell targets for hepatitis C therapy
He, Y, Duan, W, and Tan, SL
Drug Discov Today 2007.
12(5-6): 209-17
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
60319 OI-LS-369;
PUBMED-OI-3/5/2007
Inhibition of Chitin Synthases and Antifungal Activities by
2'-Benzoyloxycinnamaldehyde from Pleuropterus ciliinervis and Its
Derivatives
Kang, TH, Hwang, EI, Yun, BS, Park, KD, Kwon, BM, Shin, CS, and Kim,
SU
Biol Pharm Bull 2007.
30(3): 598-602
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
60320 OI-LS-369;
SCIFINDER-OI-2/26/2007
Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase
and inhibitors of Mycobacterium tuberculosis growth
Long, Mary C, Allan, Paula W, Luo, Mei-Zhen, Liu, Mao-Chin, Sartorelli,
Alan C, and Parker, William B
Journal of Antimicrobial Chemotherapy 2007. 59(1): 118-121
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
60321 OI-LS-369;
PUBMED-OI-3/5/2007
Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into
Cells
Cai, Z, Cai, L, Jiang, J, Chang, KS, van, der Westhuyzen DR, and Luo,
G
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
60322 OI-LS-369;
PUBMED-OI-3/5/2007
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier
protein reductase and implications for the development of antiparasitic
agents
Muench, SP, Prigge, ST, McLeod, R, Rafferty, JB, Kirisits, MJ, Roberts,
CW, Mui, EJ, and Rice, DW
Acta Crystallogr D Biol Crystallogr 2007. 63(Pt 3): 328-38
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
60323 OI-LS-369;
SCIFINDER-OI-2/26/2007
Mycolic acids for the control of tuberculosis
Sekanka, Gianna, Baird, Mark, Innikin, David, and Grooten,
Johan
Expert Opinion on Therapeutic Patents 2007. 17(3): 315-331
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
60324 OI-LS-369;
PUBMED-OI-3/5/2007
Modeling the combination of Amphotericin B, Micafungin, and Nikkomycin Z
against Aspergillus fumigatus in vitro using a novel response surface
paradigm
Brun, YF, Dennis, CG, Greco, WR, Bernacki, RJ, Pera, PJ, Bushey, JJ,
Youn, RC, White, DB, and Segal, BH
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
60325 OI-LS-369;
PUBMED-OI-3/5/2007
Hepatitis C virus infection
Fischler, B
Semin Fetal Neonatal Med 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
60326 OI-LS-369;
SCIFINDER-OI-2/26/2007
Discovery of novel phenoxyacetic acid derivatives as antimycobacterial
agents
Ali, Mohamed Ashraf and Shaharyar, Mohammad
Bioorganic & Medicinal Chemistry 2007. 15(5): 1896-1902
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
60327 OI-LS-369;
PUBMED-OI-3/5/2007
A focused salivary gland infection with attenuated MCMV: An animal model
with prevention of pathology associated with systemic MCMV
infection
Pilgrim, MJ, Kasman, L, Grewal, J, Bruorton, ME, Werner, P, London, L,
and London, SD
Exp Mol Pathol
2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
60328 OI-LS-369;
PUBMED-OI-3/5/2007
Design, synthesis, and antiviral properties of 4'-substituted
ribonucleosides as inhibitors of hepatitis C virus replication: The discovery of
R1479
Smith, DB, Martin, JA, Klumpp, K, Baker, SJ, Blomgren, PA, Devos, R,
Granycome, C, Hang, J, Hobbs, CJ, Jiang, WR, Laxton, C, Pogam, SL, Leveque, V,
Ma, H, Maile, G, Merrett, JH, Pichota, A, Sarma, K, Smith, M, Swallow, S,
Symons, J, Vesey, D, Najera, I, and Cammack, N
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
60329 OI-LS-369;
SCIFINDER-OI-2/26/2007
Mycobacterium tuberculosis with extensive resistance
Labie Dominique
Med Sci (Paris) 2007.
23(2): 205-9.
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
60330 OI-LS-369;
PUBMED-OI-3/5/2007
Neopeltolide, a Macrolide from a Lithistid Sponge of the Family
Neopeltidae
Wright, AE, Botelho, JC, Guzman, E, Harmody, D, Linley, P, McCarthy, PJ,
Pitts, TP, Pomponi, SA, and Reed, JK
J Nat Prod 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
60331 OI-LS-369;
SCIFINDER-OI-2/26/2007
Functional characterization of the acyl-[acyl carrier protein] ligase in
the Cryptosporidium parvum giant polyketide synthase
Fritzler, Jason M and Zhu, Guan
International Journal for Parasitology 2007. 37(3-4): 307-316
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
60332 OI-LS-369;
SCIFINDER-OI-2/26/2007
Constructing biodiverse gene fragment libraries and screening of the
library for bioactive polypeptide products
Watt, Paul Michael, Thomas, Wayne Robert, and Hopkins,
Richard
PATENT: US
2007031832 ISSUE DATE: 20070208
APPLICATION: 2006-22045 PP:
174pp., Cont.-in-part of U.S. Ser. No. 372,003.
ASSIGNEE: (Phylogica
Limited, Australia
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
60333 OI-LS-369;
SCIFINDER-OI-2/26/2007
Fatty acid biosynthesis as a drug target in apicomplexan
parasites
Goodman, CD and McFadden, GI
Current Drug Targets 2007.
8(1): 15-30
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
60334 OI-LS-369;
SCIFINDER-OI-2/26/2007
Pseudoceratins A and B, Antifungal Bicyclic Bromotyrosine-Derived
Metabolites from the Marine Sponge Pseudoceratina purpurea
Jang, Jae-Hyuk, Van Soest, Rob WM, Fusetani, Nobuhiro, and Matsunaga,
Shigeki
Journal of Organic Chemistry 2007. 72(4): 1211-1217
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
60335 OI-LS-369;
PUBMED-OI-3/5/2007
Chemical genetics approach to hepatitis C virus replication: cyclophilin
as a target for anti-hepatitis C virus strategy
Watashi, K and Shimotohno, K
Rev Med Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
19.
60336 OI-LS-369;
SCIFINDER-OI-2/26/2007
Study on the substituents' effects of a series of synthetic chalcones
against the yeast Candida albicans
Batovska, D, Parushev, St, Slavova, A, Bankova, V, Tsvetkova, I, Ninova,
M, and Najdenski, H
European Journal of Medicinal Chemistry 2007. 42(1): 87-92
View Data on the NIAID Therapeutics Website
HYPERLINK:
20.
60337 OI-LS-369;
SCIFINDER-OI-2/26/2007
Synthesis and biological activity studies of Di- and mono-halogenofluoro
benzenes
Logoglu, Elif, Katircioglu, Hikmet, Tilki, Tahir, and Oktemer,
Atilla
Asian Journal of Chemistry 2007. 19(3): 2029-2035
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
60338 OI-LS-369;
SCIFINDER-OI-2/26/2007
Design of endoperoxides with anti-Candida activity
Avery, Thomas D, Macreadie, Peter I, Greatrex, Ben W, Robinson, Tony V,
Taylor, Dennis K, and Macreadie, Ian G
Bioorganic & Medicinal Chemistry 2007. 15(1): 36-42
View Data on the NIAID Therapeutics Website
HYPERLINK:
22.
60339 OI-LS-369;
SCIFINDER-OI-2/26/2007
Synthesis and characterization of
1-(carbalkoxymethyl)-4-hydroxy-1-methylpiperidinium chlorides
Dega-Szafran, Zofia, Dulewicz, Ewa, and Brycki,
Bogumil
ARKIVOC (Gainesville, FL, United States) 2007.(6):
90-102
View Data on the NIAID Therapeutics Website
HYPERLINK:
23.
60340 OI-LS-369;
PUBMED-OI-3/5/2007
Inositol-1-phosphate synthetase mRNA as a new target for antisense
inhibition of Mycobacterium tuberculosis
Li, Y, Chen, Z, Li, X, Zhang, H, Huang, Q, Zhang, Y, and Xu,
S
J Biotechnol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
24.
60341 OI-LS-369;
PUBMED-OI-3/5/2007
Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity
Assay
Breger, J, Fuchs, BB, Aperis, G, Moy, TI, Ausubel, FM, and Mylonakis,
E
PLoS Pathog 2007.
3(2): e18
View Data on the NIAID Therapeutics Website
HYPERLINK:
25.
60342 OI-LS-369;
SCIFINDER-OI-2/26/2007
In Vitro Antifungal Activities of Sulfa Drugs against Clinical Isolates
of Aspergillus and Cryptococcus Species
Hanafy Ahmed, Uno Jun, Mitani Hiroki, Kang Yingqian, and Mikami
Yuzuru
Nippon Ishinkin Gakkai Zasshi 2007. 48(1): 47-50.
View Data on the NIAID Therapeutics Website
HYPERLINK:
26.
60343 OI-LS-369;
SCIFINDER-OI-2/26/2007
Hepatitis c serine protease inhibitors and uses therefor
Campbell, David Alan, Winn, David T, Betancort, Juan Manuel, and
Hepperle, Michael E
PATENT: WO
2007016476 ISSUE DATE: 20070208
APPLICATION: 2006 PP:
107pp.
ASSIGNEE: (Phenomix
Corporation, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
27.
60344 OI-LS-369;
WOS-OI-2/26/2007
Salicylanilide acetates: Synthesis and antibacterial
evaluation
Vinsova, J, Imramovsky, A, Buchta, V, Ceckova, M, Dolezal, M, Stand, F,
Jampilek, J, and Kaustova, J
MOLECULES 2007.
12(1): 1-12, 12
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243883000001
28.
60345 OI-LS-369;
SCIFINDER-OI-2/26/2007
Preparation of diaryl substituted pyrimidine-2,4-(1H)-diones as novel
bio-active compounds
Tadiparthi, Ravikumar, Sharma, Ganapavarapu Veera Raghava, Narayanan,
Sukunath, Parameswaran, Venkatesan, Reddy, Gaddam Om, Rajagopal, Sriram,
Natarajan, Manikandan, and Koppolu, Kesavan
PATENT: WO
2007007161 ISSUE DATE: 20070118
APPLICATION:
2006 PP:
67pp.
ASSIGNEE: (Orchid Research
Laboratories Limited, India
View Data on the NIAID Therapeutics Website
HYPERLINK:
29.
60346 OI-LS-369;
SCIFINDER-OI-2/26/2007
Preparation of 7-(1-piperazinyl)-4(1H)-quinolinones as antiviral
agents
Schohe-Loop,
Rudolf, Zimmermann, Holger, Henninger, Kerstin, Lang, Dieter, Thede, Kai,
Fuerstner, Chantal, and Brueckner, David
PATENT: WO
2007003308 ISSUE DATE: 20070111
APPLICATION: 2006 PP:
120pp.
ASSIGNEE: (Aicuris Gmbh
& Co. KG, Germany
View Data on the NIAID Therapeutics Website
HYPERLINK:
30.
60347 OI-LS-369;
SCIFINDER-OI-2/26/2007
Novel therapies for cytomegalovirus disease
Steininger, Christoph
Recent Patents on Anti-Infective Drug Discovery 2007. 2(1 ): 53-72
View Data on the NIAID Therapeutics Website
HYPERLINK:
31.
60348 OI-LS-369;
SCIFINDER-OI-2/26/2007
Anti fungal screening utilizing polypeptides associated with cell wall
synthesis
Van den Hondel, Cornelis Antonius Maria Jacobus
Johannes
PATENT: WO
2007011221 ISSUE DATE: 20070125
APPLICATION: 2006 PP:
38pp.
ASSIGNEE: (Universiteit
Leiden, Neth.
View Data on the NIAID Therapeutics Website
HYPERLINK:
32.
60349 OI-LS-369;
WOS-OI-2/26/2007
The chemokine receptor CXCR3 attenuates the control of chronic
Mycobacterium tuberculosis infection in BALB/c mice
Chakravarty, SD, Xu, JY, Lu, B, Gerard, C, Flynn, J, and Chan,
J
JOURNAL OF IMMUNOLOGY 2007.
178(3): 1723-1735, 13
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243820900057
33.
60350 OI-LS-369;
WOS-OI-2/26/2007
Hsp90 inhibitors suppress HCV replication in replicon cells and humanized
liver mice
Nakagawa, S, Umehara, T, Matsuda, C, Kuge, S, Sudoh, M, and Kohara,
M
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2007. 353(4): 882-888, 7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243859600007
34.
60351 OI-LS-369;
WOS-OI-3/4/2007
Future therapies for hepatitis C: where do we go from
here?
Sigal, S and Jacobson, I
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY
2007. 4(2): 60-61,
2
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243966600002
35.
60352 OI-LS-369;
WOS-OI-3/4/2007
Evaluation of an intracellular pharmacokinetic in vitro infection model
as a tool to assess tuberculosis therapy
Cappelletty, DM
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2007. 29(2): 212-216, 5
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000244082300015
36.
60353 OI-LS-369;
WOS-OI-3/4/2007
A mycobacterial gene involved in synthesis of an outer cell envelope
lipid is a key factor in prevention of phagosome maturation
Robinson, N, Wolke, M, Ernestus, K, and Plum, G
INFECTION AND IMMUNITY 2007.
75(2): 581-591, 11
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243865500005
37.
60354 OI-LS-369;
WOS-OI-3/4/2007
Current status and future prospects for new therapies for pulmonary
tuberculosis
de Souza, MVN
CURRENT OPINION IN PULMONARY MEDICINE 2006. 12(3): 167-171, 5
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243918300002
38.
60355 OI-LS-369;
WOS-OI-3/4/2007
Newer diagnostics for tuberculosis and multi-drug resistant
tuberculosis
Palomino, JC
CURRENT OPINION IN PULMONARY MEDICINE 2006. 12(3): 172-178, 7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243918300003
39.
60356 OI-LS-369;
WOS-OI-3/4/2007
Mannan binding lectin and viral hepatitis
Brown, KS, Ryder, SD, Irving, WL, Sim, RB, and Hickling,
TP
IMMUNOLOGY LETTERS 2007.
108(1): 34-44, 11
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000244061400005
40.
60357 OI-LS-369;
WOS-OI-3/4/2007
Aspirin antagonism in isoniazid treatment of tuberculosis in
mice
Byrne, ST, Denkin, SM, and Zhang, Y
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2007. 51(2): 794-795, 2
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243900600061